Bachem Holding AG (SWX:BANB)

Market Cap	4.03B
Revenue (ttm)	605.26M
Net Income (ttm)	120.25M
Shares Out	74.97M
EPS (ttm)	1.60
PE Ratio	33.55
Forward PE	31.45
Dividend	0.85 (1.58%)
Ex-Dividend Date	Apr 26, 2024

Volume	85,874
Average Volume	153,328
Open	53.00
Previous Close	53.80
Day's Range	51.80 - 53.00
52-Week Range	51.80 - 91.65
Beta	0.76
RSI	32.30
Earnings Date	Jul 24, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,207
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BANB

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.